ClosedPublished 26 Sep 2025

Denali /
Semnur Pharmaceuticals, Inc.

Denali completes business combination with Semnur Pharmaceuticals, Inc.

Buy side: Denali
Buy sideDenali
Target: Semnur Pharmaceuticals, Inc.
TargetSemnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. · 26 Sep 2025Source
Buy side: Denali
Buy sideDenali
Target: Semnur Pharmaceuticals, Inc.
TargetSemnur Pharmaceuticals, Inc.
01 / BuyerDenali
02 / TargetSemnur Pharmaceuticals, Inc.
Source for the buyer and target: Semnur Pharmaceuticals, Inc.

For the buyer and target.

“In connection with the consummation of the Business Combination, Denali changed its name to “Semnur Pharmaceuticals, Inc.””

Published 26 Sep 2025

Open the source
01

What happened

Denali completed its business combination with Semnur Pharmaceuticals, Inc., with Semnur becoming a wholly owned subsidiary of Denali. [01]

Denali was renamed Semnur Pharmaceuticals, Inc., which continues as a public company. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Semnur Pharmaceuticals, Inc.

Denali completes business combination with Semnur Pharmaceuticals, Inc.

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Semnur Pharmaceuticals, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.